Brief: Cytrx Corp issued 1.6 mln shares for benefit of claimants of IN RE Cytrx securities litigation
May 27 (Reuters) -
* Cytrx Corp says on May 25, 2016, issued for benefit of
claimants in matter of IN RE Cytrx Securities litigation total
of 1.6 million shares of stock
* Cytrx Corp says shares were issued pursuant to court's
judgment and order granting final approval of previously
announced settlement of matter
* Cytrx Corp says for purposes of this settlement, the
shares were valued at an aggregate of $4.5 million - SEC Filing
Source - http://1.usa.gov/1U0Sgqg
(Bengaluru Newsroom; +1 646 223 8780)
Recent news on LadRx
See all newsBrief: Ladrx Issues 2024 Update To Shareholders
Brief: LadRx Completes Non-Dilutive Financing Transaction For Up To $11 Mln With Xoma Corporation
Brief: LadRx Intends To Apply To List Stock On Nasdaq Under Symbol 'LADX'
Brief: LadRx Announces Review Of Strategic Alternatives, Provides Corporate Updates
Brief: CytRx Highlights Orphazyme's Update On Productive Meeting With FDA Regarding Arimoclomol In Niemann-Pick Disease Type C